Foundation Harsaul serves as Executive at Osmotica Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Foundation Harsaul has executed 4 insider transactions totaling $7.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 20, 2023 involved selling 4,758,899 shares valued at $142.8K.
Foundation Harsaul currently holds 4,941,101 shares of Osmotica Pharmaceuticals plc (OSMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Foundation Harsaul has been a net buyer of OSMT stock. They have purchased $6.3M and sold $816.2K worth of shares.
Foundation Harsaul's most recent insider trade was on Oct 20, 2023, when they sold 4,758,899 shares at $0.03 per share.
Get notified when new Form 4 filings are submitted
| $0.05 |
| Discretionary |
| Oct 18, 2023 | RVLP | $205.3K | Sale | 3,421,537 | $0.06 | Discretionary |
| Jan 13, 2020 | OSMT | $6.3M | Purchase | 1,250,000 | $5.00 | Discretionary |